Bryce Chackerian, Ph.D.

Molecular Genetics and Microbiology
MSC08 4660
1 University of New Mexico
Albuquerque, NM 87131-0001
 
Office: BRF 323D
Tel: (505) 272-0269
Fax: (505) 272-6029
E-mail: bchackerian@salud.unm.edu

Vaccines for chronic and infectious diseases based on Virus-like Particles

Research Interests

Dr. Chackerian's laboratory is interested in vaccine development; particularly the use of virus particles as platforms for antigen display.  It has long been recognized that highly dense repetitive antigens such as virus particles induce strong immune responses.  However, more recent studies from Dr. Chackerian's laboratory has demonstrated that  antigens that are normally poorly immunogenic can be made highly immunogenic by displaying them in a multivalent, repetitive format on the surface of virus particles; essentially using viruses as platforms for vaccines.  Dr. Chackerian has shown that this ability to enhance immunogenicity does not only apply to epitopes derived from traditional targets, such as pathogens, but also to self-antigens which are normally subject to the mechanisms of B cell tolerance.  Using virus-like particles derived from RNA bacteriophage, he has been collaborating with Dr. David Peabody (also a member of MGM) to develop and implement a system that allows vaccines to be rapidly identified by affinity selection.  He also has funded projects to develop novel vaccines targeting Human Papillomavirus and HIV.

Selected Publications

Link to PubMed


Hunter, Z., Tumban, E., Dziduszko, A., and B. Chackerian (2011). Aerosol delivery of Virus-like particles to the genital tract induces local and systemic antibody responses.  Vaccine. May 5. [Epub ahead of print]

Chackerian, B., Caldeira, J. D., Peabody, J., and D. S. Peabody (2011).  Peptide Epitope Identification by Affinity Selection on Bacteriophage MS2 Virus-like Particles.  Journal of Molecular Biology. Jun 3;409(2):225-37. Epub 2011 Apr 9.

Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P.A., Hanna, T.N., Liu, J., Phillips, B., Carter, M. B., Carroll, N. J., Jiang, X., Dunphy, D. R., Wilman, C.L., Petsev, D.N., Evans, D. G., Parikh, A. N., Chackerian, B., Wharton, W., Peabody, D.S., and C. J. Brinker (2011). The Targeted Delivery of Multicomponent Cargos to Cancer by Nanoporous Particle-Supported Lipid Bilayers.  Nature Materials, May; 10(5): 389-397. Epub 2011 Apr 17.

Caldeira, J.D., Medford, A., Kines, R.C., Lino, C.A., Schiller, J.T., Chackerian, B., and D.S. Peabody (2010).  Immunogenic Display of Diverse Peptides, Including a Broadly Cross-Type Neutralizing Human Papillomavirus L2 epitope, on Virus-like Particles of the RNA Bacteriophage PP7.  Vaccine, 28 (27), 4384-4393. Epub 2010 Apr 29.

Li, Q.Y. Gordon, M. N., Chackerian, B., Alamed, J., Ugen, K. E., and D. Morgan (2010).  Virus-like Peptide Vaccines Against Aß N-terminal or C-terminal Domains Reduce Amyloid Deposition in APP Transgenic Mice without Addition of Adjuvant.  Journal of Neuroimmune Pharmacology, 5 (1), 133-42.

Hunter, Z., Smyth, H. D., Durfee, P., and B. Chackerian (2009).  Induction of mucosal and systemic antibody responses by aerosol delivery and intramuscular immunization of Virus-like Particle based vaccines targeting CCR5.  Vaccine, 28 (2), 403-414. Epub 2009 Oct 20.

Peabody, D. S., Manifold-Wheeler, B., Medford, A., Jordan, S. K. Caldeira, J., and B. Chackerian (2008). Immunogenic Display of Diverse Peptides on Virus-Like Particles of RNA Phage MS2. Journal of Molecular Biology, 380, 252-263.

Chackerian, B. Durfee, M. R., and J. T. Schiller (2008). Virus-like Display of a Neo-self Antigen Reverses B cell Anergy in a B cell Receptor Transgenic Mouse Model. Journal of Immunology, 180 (9), 5816-5825. B. Chackerian (2007). Virus-like Particles: Flexible Platforms for Vaccine Development.  Expert Reviews of Vaccines 6 (3), 381-390.

Chackerian, B., Rangel, M., Hunter, Z., and D. S. Peabody (2006).  Virus and virus-like particle based immunogens for Alzheimer's disease induce antibody responses against Amyloid-Beta without concomitant T cell responses.  Vaccine 24 (37-39),  6321-6331.

Chackerian, B., Briglio, L., Albert, P. S., Lowy, D. R., and J. T. Schiller (2004).  Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic Simian/Human Immunodeficiency Virus.  Journal of Virology 78 (8), 4037-4047.

Li, Q., Cao, C., Chackerian, B., Schiller, J. T., Gordon, M., Ugen, K. E., and D. Morgan (2004).  Overcoming Antigen Masking of Anti-Abeta Antibodies Reveals Breaking of B cell Tolerance in Abeta Immunized Amyloid Precursor Protein Transgenic Mice.  BMC Neuroscience 5: 21 (8 June 2004).

Chackerian, B., Lenz, P., Lowy, D. R., and J. T. Schiller (2002).  Determinants of autoantibody induction by conjugated papillomavirus virus-like particles.  Journal of Immunology 169 (11), 6120-6126.

Chackerian, B., Lowy, D. R., and J. T. Schiller (2001).  Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. Journal of Clinical Investigation 108 (3), 415-423.

Chackerian, B., Lowy, D. R., and J. T. Schiller (1999).  Induction of auto-antibodies to mouse CCR5 with recombinant papillomavirus particles.  Proceedings of the National Academy of Sciences USA 96 (5), 2373-2378.